|
Index of reports
> Cases resulting in a serious event (203)
> Cases with Drug Exposure During Pregnancy (21)
Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in a serious event where reactions include drug exposure during pregnancy.
Adverse event in receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from United States on 2007-10-19
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Hypospadias
Suspect drug(s):
Viracept
Administration route: Oral
Indication: HIV Infection
Videx
Sustiva
Epivir
Norvir
Retrovir
Indinivir Sulfate
Adverse event in 27 year old female receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-18
Patient: 27 year old female
Adverse reactions / side effects: Cholestasis of Pregnancy, Drug Exposure During Pregnancy, Proteus Infection, Anogenital Warts, Genital Infection
Suspect drug(s):
Combivir
Dosage: 900mg per day
Administration route: Oral
Start date: 2005-02-16
Epivir
Dosage: 300mg per day
Administration route: Oral
Start date: 2004-07-29
End date: 2005-02-16
Viread
Dosage: 300mg per day
Start date: 2004-07-29
Norvir
Dosage: 400mg per day
Start date: 2004-07-29
End date: 2005-02-16
Fuzeon
Dosage: 180mg per day
Start date: 2005-03-22
End date: 2005-03-31
Invirase
Dosage: 2000mg per day
Start date: 2004-09-29
End date: 2005-02-16
Adverse event in 28 year old female receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-06-25
Patient: 28 year old female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Drug Dependence, Treatment Noncompliance
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Retrovir
Administration route: Oral
Indication: HIV Infection
Viracept
Administration route: Oral
Indication: HIV Infection
Morphine
Administration route: Oral
Adverse event in receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-06-25
Patient:
Adverse reactions / side effects: Agitation, Overdose, Body Temperature Increased, Drug Exposure During Pregnancy, Abdominal Distension, Sneezing, Feeding Disorder Neonatal, Faecaloma
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Indication: HIV Infection
Retrovir
Indication: HIV Infection
Epivir
Administration route: Oral
Indication: Antiviral Prophylaxis
Retrovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Morphine
Viracept
Indication: HIV Infection
Viracept
Administration route: Oral
Indication: Antiviral Prophylaxis
Adverse event in female receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-06-14
Patient: female
Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Zerit
Dosage: ongoing gestational weeks 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Videx
Dosage: ongoing at gestational weeks 2 through 10
Indication: HIV Infection
Start date: 1997-05-29
End date: 1997-07-01
Fortovase
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Retrovir
Dosage: initiated at gestational week 10
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Retrovir
Dosage: infusion at delivery
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Crixivan
Dosage: ongoing gestational week 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Epivir
Dosage: 6 week course after birth
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Adverse event in 31 year old female receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-06-07
Patient: 31 year old female, weighing 60.5 kg (133.1 pounds)
Adverse reactions / side effects: Umbilical Cord Abnormality, Drug Exposure During Pregnancy, Intra-Uterine Death, Placental Infarction, Abortion Spontaneous
Suspect drug(s):
Didanosine
Dosage: 250 mg, qd, oral
Administration route: Oral
Indication: Retroviral Infection
Start date: 2004-09-01
Norvir
Dosage: 100 mg/day, oral
Administration route: Oral
Indication: Retroviral Infection
Fuzeon
Dosage: 90 mg, bid, subcutaneous
Indication: Retroviral Infection
Valganciclovir HCL
Indication: Cytomegalovirus Test
Start date: 2004-09-01
Reyataz(atazanvir)
Dosage: 300 mg/day, oral
Administration route: Oral
Indication: Retroviral Infection
Epivir
Indication: Retroviral Infection
Cotrim
Indication: Prophylaxis
Start date: 2004-01-01
Lamivudine
Dosage: 300 mg/day, oral
Administration route: Oral
Adverse event in 28 month old female receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-29
Patient: 28 month old female
Adverse reactions / side effects: Electroencephalogram Abnormal, Drug Exposure During Pregnancy, Nervous System Disorder, Nuclear Magnetic Resonance Imaging Abnormal, Pregnancy
Adverse event resulted in: hospitalization
Suspect drug(s):
Zerit
Dosage: from the 26th week of gestation.
Start date: 1998-01-14
Videx
Dosage: from the 26th week of gestation.
Start date: 1998-01-14
Retrovir
Dosage: from the 13th week to the 26th week of gestation.
Start date: 1997-10-01
End date: 1998-01-01
Invirase
Dosage: from the 17th week to the end of pregnancy.
Start date: 1997-11-01
End date: 1998-04-01
Norvir
Dosage: from the 17th week to the end of pregnancy.
Start date: 1997-11-01
End date: 1998-04-01
Epivir
Dosage: from the 17th week of gestation to the 26th week.
Start date: 1997-11-01
End date: 1998-04-01
Epivir
Dosage: syrup
Administration route: Oral
Start date: 1997-11-01
End date: 1998-01-01
Retrovir
Dosage: syrup
Administration route: Oral
Start date: 1997-10-01
End date: 1998-01-01
Adverse event in male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-05-09
Patient: male, weighing 2.8 kg (6.2 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Congenital Anomaly, Diaphragmatic Hernia, Pregnancy
Suspect drug(s):
Combivir
Dosage: 900mg per day
Start date: 2005-02-16
Epivir
Dosage: 300mg per day
Start date: 2004-07-29
End date: 2005-02-16
Viread
Dosage: 300mg per day
Start date: 2004-07-29
Norvir
Dosage: 400mg per day
Start date: 2004-07-29
End date: 2005-02-16
Fuzeon
Dosage: 180mg per day
Start date: 2005-03-22
End date: 2005-03-31
Invirase
Dosage: 2000mg per day
Start date: 2004-09-29
End date: 2005-02-16
Adverse event in 38 year old female receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-05-07
Patient: 38 year old female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Induced, Cervical Dysplasia, Ectopic Pregnancy
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-06-01
Combivir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-12-21
Other drugs received by patient: Reyataz; Norvir; Viread; Truvada; Invirase
Adverse event in receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-03
Patient:
Adverse reactions / side effects: Vertical Infection Transmission, Drug Exposure During Pregnancy, Human Immunodeficiency Virus Transmission, Maternal Condition Affecting Foetus, Failure TO Thrive, Hepatosplenomegaly
Suspect drug(s):
Retrovir
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Epivir
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Nevirapine
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Quinine Sulfate
Dosage: transplacentary
Indication: Plasmodium Falciparum Infection
Adverse event in 32 year old female receiving Epivir (Lamivudine)
Reported by a physician from Botswana on 2007-03-29
Patient: 32 year old female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous, Ectopic Pregnancy
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-02-13
Zerit
Dosage: 60mg per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2004-02-13
Viramune
Dosage: 400mg per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2005-03-18
Sustiva
Dosage: 600mg per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2004-02-13
End date: 2005-03-18
Adverse event in receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-27
Patient:
Adverse reactions / side effects: Congenital Hydronephrosis, Drug Exposure During Pregnancy, Normal Delivery
Suspect drug(s):
Epivir
Dosage: 300mg per day
Indication: HIV Infection
Start date: 2006-04-20
End date: 2006-06-24
Combivir
Dosage: 2tab per day
Indication: HIV Infection
Start date: 2006-06-27
Other drugs received by patient: Zerit; Sustiva; Reyataz; Norvir
Adverse event in female receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-03-05
Patient: female
Adverse reactions / side effects: Cleft LIP and Palate, Drug Exposure During Pregnancy, Anaemia, Drug Exposure VIA Breast Milk
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Indication: HIV Infection
Start date: 2004-02-13
Retrovir
Dosage: 400mg per day
Indication: HIV Infection
Start date: 2004-02-13
Viracept
Dosage: 2500mg per day
Indication: HIV Infection
Start date: 2004-02-13
Retrovir
Dosage: .46ml four times per day
Administration route: Oral
Start date: 2004-06-22
End date: 2004-08-03
Other drugs received by patient: Lopemin; Ferrum; Utemerin
Adverse event in receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from South Africa on 2007-02-21
Patient:
Adverse reactions / side effects: Nose Deformity, Drug Exposure During Pregnancy, Premature Baby, Talipes, Limb Malformation
Suspect drug(s):
Epivir
Dosage: 150mg per day
Indication: HIV Infection
Start date: 2005-02-23
Retrovir
Dosage: 600mg per day
Indication: HIV Infection
Start date: 2005-12-29
Zerit
Dosage: 80mg per day
Indication: HIV Infection
Start date: 2005-02-23
End date: 2005-12-29
Sustiva
Dosage: 600mg per day
Indication: HIV Infection
Start date: 2005-02-23
End date: 2005-12-29
Viramune
Dosage: 400mg per day
Indication: HIV Infection
Start date: 2005-12-29
Adverse event in male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from Malaysia on 2007-02-12
Patient: male
Adverse reactions / side effects: Diarrhoea Neonatal, Hyperlactacidaemia, Anion GAP Increased, Coagulopathy, Dyskinesia, Blood Albumin Decreased, Prothrombin Time Prolonged, Neonatal Disorder, Activated Partial Thromboplastin Time Prolonged, Caesarean Section, Hepatic Encephalopathy, Vertical Infection Transmission, Gamma-Glutamyltransferase Increased, Developmental Delay, HIV Infection, Fever Neonatal, Abdominal Distension, Alanine Aminotransferase Increased, Vomiting Neonatal, Convulsion, Drug Exposure During Pregnancy, Dehydration, Aspartate Aminotransferase Increased, Maternal Condition Affecting Foetus, Ammonia Increased, Feeding Disorder
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Retrovir
Dosage: oral
Administration route: Oral
Epivir
Dosage: transplacentary
Indication: HIV Infection
Stavudine
Dosage: transplacentary
Indication: HIV Infection
Nevirapine
Dosage: transplacentary
Indication: HIV Infection
Retrovir
Dosage: transplacentary
Indication: HIV Infection
Adverse event in receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-09
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Congenital Hydronephrosis
Suspect drug(s):
Epivir (Lamivudine)
Other drugs received by patient: Zerit; Sustiva; Reyataz; Norvir
Adverse event in 6 month old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-01-25
Patient: 6 month old male, weighing 2.5 kg (5.5 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Epilepsy
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Retrovir
Dosage: .38ml per day
Start date: 2004-09-23
End date: 2004-09-24
Retrovir
Administration route: Oral
Start date: 2004-09-26
End date: 2004-11-18
Retrovir
Dosage: .7ml three times per day
Administration route: Oral
Start date: 2004-10-26
End date: 2004-11-18
Epivir
Dosage: 400mg per day
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Retrovir
Dosage: 300mg per day
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Viramune
Start date: 2004-09-22
End date: 2004-09-23
Viracept
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Viracept
Dosage: 280mg twice per day
Administration route: Oral
Start date: 2004-10-26
End date: 2004-11-18
Marijuana
Other drugs received by patient: Viramune; Bactrim; Espo; Glucose; Glucose
Adverse event in male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-01-19
Patient: male
Adverse reactions / side effects: Paresis Cranial Nerve, Vomiting, Visual Acuity Reduced, Neoplasm, Somnolence, Strabismus, Papilloedema, Diplopia, Pinealoblastoma, Fatigue, Drug Exposure During Pregnancy, Hydrocephalus
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 1998-04-28
End date: 1998-06-05
Epivir
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 1998-04-28
End date: 1998-06-05
Other drugs received by patient: Retrovir; Epivir; Retrovir; Clamoxyl
Adverse event in male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-01-12
Patient: male
Adverse reactions / side effects: Drug Exposure During Pregnancy, Hypospadias
Suspect drug(s):
Epivir
Indication: HIV Infection
Retrovir
Indication: HIV Infection
Viracept
Indication: HIV Infection
Adverse event in female receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-01-09
Patient: female, weighing 3.0 kg (6.6 pounds)
Adverse reactions / side effects: Foetal Distress Syndrome, Cardiac Murmur, C-Reactive Protein Increased, Drug Exposure During Pregnancy, Meconium in Amniotic Fluid, Electrocardiogram T Wave Abnormal, Tricuspid Valve Incompetence, Cardiac Hypertrophy
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Indication: Antiviral Prophylaxis
Start date: 1997-09-01
Rifadin
Indication: Pulmonary Tuberculosis
Start date: 1997-07-01
Rimifon
Indication: Pulmonary Tuberculosis
Start date: 1997-07-01
Zerit
Indication: Antiviral Prophylaxis
Start date: 1997-09-01
Other drugs received by patient: Retrovir; Epivir; Retrovir; Videx; Anti-Tuberculosis Medication
Adverse event in 19 year old female receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-01-08
Patient: 19 year old female
Adverse reactions / side effects: Premature Baby, Drug Exposure During Pregnancy, Anaemia
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-06-05
Retrovir
Dosage: 1mgkh per day
Indication: HIV Infection
Start date: 2006-10-24
End date: 2006-10-24
Zidovudine
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-06-05
Other drugs received by patient: Kaletra; Viracept; Trimethoprim + Sulfamethoxazole; Macrobid; Clotrimazole Troches; Reglan; Promethazine; Cefazolin
|
